Susquehanna International Group, LLP Dia Medica Therapeutics Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 32,796 shares of DMAC stock, worth $171,195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,796
Previous 556,593
94.11%
Holding current value
$171,195
Previous $2.11 Million
93.98%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DMAC
# of Institutions
58Shares Held
5.97MCall Options Held
14.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.54MShares$8.01 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX650KShares$3.39 Million4.32% of portfolio
-
Geode Capital Management, LLC Boston, MA630KShares$3.29 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$3.17 Million0.01% of portfolio
-
Bleichroeder LP New York, NY382KShares$2 Million0.47% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $138M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...